Analyst
Freedom Capital Markets
Equibles does not estimate personal net worth.
Keith Hinton is recorded as Analyst at Freedom Capital Markets. Keith Hinton has spoken on 13 earnings calls and 8 other investor events across 8 companies, most recently for Lemaitre Vascular Inc on September 22, 2026. Those appearances were for Lemaitre Vascular Inc (LMAT), GeneDx Holdings Corp. (WGS), Enovis CORP (ENOV), Veracyte, Inc. (VCYT), LivaNova PLC (LIVN) and 3 other companies. The companies whose calls Keith Hinton spoke on are classified in the Healthcare sector.
“So apologies if this has already been addressed. I'm jumping around a little bit, but just in terms of catheters in the quarter, was that just simply a tough year over year comp, or is there any sort of durable change going on there in terms of competitive dynamics?”
“So apologies if this has already been addressed. I'm jumping around a little bit, but just in terms of catheters in the quarter, was that just simply a tough year over year comp, or is there any sort of durable change going on there in terms of competitive dynamics?”
“Yeah, a couple of P&L cash flow questions here, starting off with the inflation figure that you put out. I think you said about a $10 million impact.”
“And then just on the ASP side, can you talk a little bit about payer mix within epilepsy and whether you're seeing, you know, the benefit from the increase in CMS reimbursement?”
“Can you talk a little bit about where the penetration rate is for EOS Insight into the installed base, kind of what your goals are for the next, say, 12 to 24 months?”
Freedom Capital Markets
Analyst
Source not stated
Medical Instruments & Supplies · Healthcare
Diagnostics & Research · Healthcare
ENOV
Medical Devices · Healthcare
VCYT
Diagnostics & Research · Healthcare
LIVN
Medical Devices · Healthcare
ATRC
Medical Instruments & Supplies · Healthcare
GMED
Medical Devices · Healthcare
